Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

APOL1 and progression of nondiabetic nephropathy.

Palmer ND, Freedman BI.

J Am Soc Nephrol. 2013 Sep;24(9):1344-6. doi: 10.1681/ASN.2013060589. Epub 2013 Jun 27. No abstract available.

2.

APOL1 variants associate with increased risk of CKD among African Americans.

Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH.

J Am Soc Nephrol. 2013 Sep;24(9):1484-91. doi: 10.1681/ASN.2013010113. Epub 2013 Jun 13.

3.

Population-based risk assessment of APOL1 on renal disease.

Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR.

J Am Soc Nephrol. 2011 Nov;22(11):2098-105. doi: 10.1681/ASN.2011050519. Epub 2011 Oct 13.

4.

Health disparities in kidney disease--emerging data from the human genome.

Williams WW, Pollak MR.

N Engl J Med. 2013 Dec 5;369(23):2260-1. doi: 10.1056/NEJMe1312797. Epub 2013 Nov 9. No abstract available.

PMID:
24206461
5.

High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.

Ulasi II, Tzur S, Wasser WG, Shemer R, Kruzel E, Feigin E, Ijoma CK, Onodugo OD, Okoye JU, Arodiwe EB, Ifebunandu NA, Chukwuka CJ, Onyedum CC, Ijoma UN, Nna E, Onuigbo M, Rosset S, Skorecki K.

Nephron Clin Pract. 2013;123(1-2):123-8. doi: 10.1159/000353223. Epub 2013 Jul 13.

PMID:
23860441
6.

Intensive blood-pressure control in hypertensive chronic kidney disease.

Freedman BI, Sedor JR.

N Engl J Med. 2010 Dec 23;363(26):2565; author reply 2565-6. doi: 10.1056/NEJMc1011419#SA3. No abstract available.

PMID:
21175324
7.

APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators.

N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.

8.

Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.

Ito K, Bick AG, Flannick J, Friedman DJ, Genovese G, Parfenov MG, Depalma SR, Gupta N, Gabriel SB, Taylor HA Jr, Fox ER, Newton-Cheh C, Kathiresan S, Hirschhorn JN, Altshuler DM, Pollak MR, Wilson JG, Seidman JG, Seidman C.

Circ Res. 2014 Feb 28;114(5):845-50. doi: 10.1161/CIRCRESAHA.114.302347. Epub 2013 Dec 30.

9.
10.

Effect of Genetic African Ancestry on eGFR and Kidney Disease.

Udler MS, Nadkarni GN, Belbin G, Lotay V, Wyatt C, Gottesman O, Bottinger EP, Kenny EE, Peter I.

J Am Soc Nephrol. 2015 Jul;26(7):1682-92. doi: 10.1681/ASN.2014050474. Epub 2014 Oct 27.

11.

Population genetics of chronic kidney disease: the evolving story of APOL1.

Wasser WG, Tzur S, Wolday D, Adu D, Baumstein D, Rosset S, Skorecki K.

J Nephrol. 2012 Sep-Oct;25(5):603-18. doi: 10.5301/jn.5000179. Review.

PMID:
22878977
12.

Should kidney donors be genotyped for APOL1 risk alleles?

Freedman BI, Julian BA.

Kidney Int. 2015 Apr;87(4):671-3. doi: 10.1038/ki.2015.16. No abstract available.

13.

APOL1 variants and kidney disease in people of recent African ancestry.

Genovese G, Friedman DJ, Pollak MR.

Nat Rev Nephrol. 2013 Apr;9(4):240-4. doi: 10.1038/nrneph.2013.34. Epub 2013 Feb 26. Review.

PMID:
23438974
14.

The new era of APOL1-associated glomerulosclerosis.

Freedman BI, Langefeld CD.

Nephrol Dial Transplant. 2012 Apr;27(4):1288-91. doi: 10.1093/ndt/gfr812. Epub 2012 Feb 2. No abstract available.

15.

Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.

Quaggin SE, George AL Jr.

J Am Soc Nephrol. 2011 Nov;22(11):1955-8. doi: 10.1681/ASN.2011090932. Epub 2011 Oct 13. No abstract available.

16.

Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Freedman BI, Skorecki K.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):2006-13. doi: 10.2215/CJN.01330214. Epub 2014 Jun 5. Review.

17.

Hypertension-misattributed kidney disease in African Americans.

Skorecki KL, Wasser WG.

Kidney Int. 2013 Jan;83(1):6-9. doi: 10.1038/ki.2012.369.

18.

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.

Riella LV, Sheridan AM.

Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3.

PMID:
26049628
19.

Is it variants in the apolipoprotein l1 gene, or blood pressure control, that predicts progression of nondiabetic hypertensive nephropathy in African Americans?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2013 Jul;15(7):445-6. doi: 10.1111/jch.12126. Epub 2013 May 17. No abstract available.

20.

APOL1 kidney risk alleles: population genetics and disease associations.

Limou S, Nelson GW, Kopp JB, Winkler CA.

Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33. doi: 10.1053/j.ackd.2014.06.005. Review.

Supplemental Content

Support Center